Cav1.3
Description: calcium channel, voltage-dependent, L type, alpha 1D subunit Gene: Cacna1d Alias: cacna1d, cav1.3, ca1.3
Cav1.3, encoded by the gene cacna1d, is a calcium channel, voltage-dependent, L type, alpha 1D subunit. It is expressed throughout the organism and is responsible for brain function, pacemaking, secretion, and hair cell architecture. Mutations of the channel are the cause of certain psychiatric disorders, deafness, and bradycardia.
In humans, cacna1d, the gene which encodes Cav1.3, is composed of 55 exons located on chromosome 3 (3p21.1).
The α1 subunit of Cav1.3 channels is subject to alternative splicing, which cannot only affect channel gating itself, but also interaction with protein partners or tissue expression.
Some important exons, often involved in alternative splicing are [2393]:
- Exons 8a and 8b
- Encodes the transmembrane segment S6 of Domain I
- Expression of 8a or 8b is mutually exclusive
- 8b is abundantly present in cochlear inner hair cells, sinoatrial node and in the brain
- Exon 11
- Encodes the cytoplasmic loop connecting domain I and domain II
- Exon 32
- Extracellular S3-S4 connecting loop of domain IV
- Exons 39 to 49
- Encode various sections of the C terminus
Species | NCBI accession | Length (nt) | |
---|---|---|---|
Human | NM_000720.4 | 9429 | |
Mouse | NM_028981.3 | 8701 | |
Rat | NM_001389225.1 | 9071 |
The human Cav1.3 protein is composed of 2161 amino acid (aa) and has a molecular weight of 245 Kda.
There exists a number of protein isoforms that arise from the translation of the aforementioned transcript variants.
Protein isoforms resulting from the alternative splicing of the C-terminus have been predominantly studied. The C-terminus is a strong target for alternative splicing due to the C-terminus gating modulator’s ability to prevent Ca2+ inactivation of the channels [2394].
- The full-length (250 kD) protein isoform (Cav1.342L) possesses all the regulatory domains and is predominant in the prenatal stages.
- Cav1.3 42A and Cav1.3 43S are short isoforms lacking distal C-terminal domains. Cav1.3 42A activates at more negative voltages and inactivates faster due to enhanced Ca2+-dependent inactivation. These isoforms' C-terminal domains compete with calmodulin (CaM) for IQ domain binding.
- Splicing of exon 41 removes the IQ motif resulting in a truncated Cav1.3 protein with diminished inactivation
- Splicing of exons 44 and 48 in-frame causes disruption of the distal modulator binding to the IQ domain
Isoforms containing exon 8b resulted in a six-amino acid difference in the pore region of repeat. They also displayed lower sensitivity to DHP antagonists, faster activation kinetics, slower inactivation compared to α1C-a currents [506]
Isoforms
Like most mammalian proteins, Cav1.3 is subject to a series of post translational modifications (PTM).
Multiple phosphorylation sites were identified in Cav1.3, with phosphorylation mediated by proteins such as AKAPS, CaMKII, PKA, and PKC, depending on channel expression location [2395]. Phosphorylation of by PKA in the proximal C-terminus cardiac neurons was shown to increase Cav1.3 activity and thereby current by 25%. [2394] Phosphorylation by PKC in the N-terminal domain reduces up to 50% Cav1.3 mediated current by reducing the open probability of the open channel [2394].
Cav1.3 calcium channels undergo A-to-I RNA editing. This PTM occurs within exon 41, and is mediated by ADAR2. The result is slower channel inactivation kinetics, ultimately influencing the firing frequency of action potentials in neurons. The edited Cav1.3 channels have been implicated in various physiological and pathological processes, including their role in the superchiasmatic nucleus and potential relevance in Alzheimer's disease. [2396]
Lika most Cav channels, Cav1.3 is made up of a single protein composed of 4 homologous domains (DI-DIV). Each domain is made up of 6 transmembrane subunits (S1-S6) connected by extracellular loops. S1-4 form the voltage sensing domain (VSD) whereas the S5-6 form the pore module (PM). The S4 subunit of each domain contains a series of positively charged residues.
When membrane depolarization occurs, these charged residues cause the movement of the S4 subunit. This translocation of the S4 helices causes further conformational rearrangements within CaV1.3 that activate the receptor and open the channel pore. [2361]
The structure of human Cav1.3 complex, comprising the pore-forming α1 and auxiliary α2δ-1 and β3 subunits, bound to cinnarizine were determined at 3.0 Å and 3.1 Å, giving us a detailed insight into the specific structural features the protein. However, it is worth noting that these experiments may not represent the canonical native conformation [2397]. However, some Cav1.3 structural specificities were highlighted:
- Cav1.3 has minor structural differences compared to Cav1.1 in the α1-interacting domain (AID). AID is responsible for the association of β subunit to α1 and serves as a lever for β subunit to regulate the gating properties of Cav channels.[2397]
- The C-terminus of Cav1.3 channels contains a modulatory domain (CTM) that interferes with CaM modulation. The CTM has two α-helices: DCRD (C-terminal end) and PCRD (after the IQ motif). These helices bind to each other, reducing open probability and CDI, and shift voltage dependence to more positive voltages. These effects are strong in Cav1.3 and Cav1.4 but weaker in Cav1.2 channels [2395]
Cav1.3 predicted AlphaFold size
Methodology for AlphaFold size prediction and disclaimer are available here
Cav1.3, along with other L-type channels, has 3 broadly-defined gating modes [2362]:
- Mode 0: the closed state of the channel
- Mode 1: brief ~1 ms opening
- Mode 2: longer opening duration due to strong depolarisation or interaction with other actors
Each of CaV1.3's four voltage sensors play a different role in the kinetics of the channel: one (VSD-I) is crucial for CaV1.3 activation, while the others (VSD-II, VSD-III, VSD-IV) trigger calcium release more rapidly. [2365]
In comparison to other L-type calcium channels, Cav1.3 opens and closes with faster kinetics. Cav1.3 was shown to activate a more negative potential compared (~70 mV) to Cav1.2 and have much faster activation kinetics. [2397] [2398] The channel also displays slower current inactivation during depolarizations, allowing for the mediation of long lasting Ca2+ influx during weak depolarization, and showed a very low open probability (about 0.15 at 20 mV: near the peak of an action potential) [506] [2398]
Single channel unitary conductance
The single channel unitary conductance of Cav1.3 is approximately 14.4 pS [2398]
Models
There are currently no genetic ion channel models available
Tissue & cellular
Cav1.3 is found expressed in both the PNS and CNS.
In the PNS, Cav1.3 has been identified in the sinoatrial node (SAN), atrioventricular node (AVN), the atria (A) of cardiac tissue [2399], endocrine cells [2395], sensory cells of the inner ear (inner and outer cochlear hair cells and vestibular hair cells [2395]
In the CNS, Cav1.3 is present in the brain, accounting for 10% of Cav current and in somatodendritic neurons [2395] [2395]
In the CNS, Cav1.3 channels are primarily located postsynaptically in the spines and shafts of dendrites [2393] [2395]
Cerebral function
Given their postsynaptic location throughout the brain, Cav1.3 shape neuronal excitability and dendritic spine morphology [[2393]. They also activate Ca2+ signaling pathways involved in ETC. ETC transforms synaptic activity patterns into neuronal remodeling associated with learning, memory, drug addiction, and neuronal development [2395]
Indeed, knock out mouse models of cacna1d have been used to study Cav1.3 LTCCs' roles in anxiety, depressive-like behavior, and fear processing. The key findings were [2400]: Anxiety: Knockdown of Cav1.3 in the prefrontal cortex (PFC) does not affect anxiety, indicating these channels do not mediate anxiety-like behavior. Depressive-like Behavior: Cav1.3 knockout mice show an antidepressant-like phenotype in the forced swim test (FST). Mutant mice insensitive to dihydropyridine (DHP) blockers exhibit depressive-like behavior when treated with the DHP activator BayK8644, suggesting Cav1.3's role in depression modulation. Fear Processing: Homozygous cacna1d knockout mice show impaired fear memory consolidation but normal extinction in contextual fear conditioning. Another study identified three significant CACNA1D SNPs associated with cocaine dependence, indicating Cav1.3 potential role in addiction. [2400]
Heart Pacemaking
Cav1.3 is also present in the heart and plays a vital role in pacemaking. Knockout mouse models showed bradycardia and arrhythmia due to sinoatrial node dysfunction [[2394]. Further experiments, causing the Inactivation of the Ca(v)1.3 gene in mice, also slowed pacemaker activity, resulting in arrhythmia in SAN cells due to the abolishing of the L-type current during diastolic depolarization [2401].
Adrenal hormone secretion
Cav1.3 is thought to play an important role in the secretion of aldosterone, a steroid hormone secreted by adrenal glands. Its main role is to regulate salt and water in the body, thus having an effect on blood pressure. The mechanisms by which this is done are poorly understood. However, as will be discussed later, disruption of Cav1.3 in the adrenal glands, leads to a number of channelopathies.
Sensory hair cells
Inner hair cells (IHCs) contain about 1700 Ca2+ channels, mainly CaV1.3, localized at ribbon-type active zones. Each active zone holds around 80 Ca2+ channels. This tight control of Ca2+ entry enables precise exocytosis signaling, particularly at low sound intensities [2402].
Cav1.3 were also shown to regulate ribbon synapse architecture in developing zebrafish sensory hair cells. Disrupting or blocking Ca(V)1.3a enlarges synaptic ribbons, while activation reduces ribbon size and intact synapses. Ca(2+) influx via Ca(V)1.3 fine-tunes ribbon size and is crucial for synaptic maintenance (23197719).
Outer hair cells (OHCs), like IHCs, fire spontaneous Ca2+-induced action potentials during immature development, driven by CaV1.3 Ca2+ channels (31661723).
Channelopathies
Psychiatric disorders
As Cav1.3 plays an important role in proper brain function, deregulation of the protein is the cause of a number of psychiatric disorders. These include:
Cav1.3 may also have a role in parkinson's disease development as Dopamine-containing neurons in the substantia nigra pars compacta rely on L-type Cav1.3 Ca2+ channels for rhythmic pacemaking, making them vulnerable to Parkinson's disease stressors. This reliance increases with age. Juvenile neurons use different pacemaking mechanisms common to unaffected neurons. Blocking Cav1.3 channels in adult neurons reverts them to juvenile pacemaking, protecting against Parkinson's disease in vitro and in vivo, suggesting a new therapeutic strategy [2404].
Deafness & bradycardia
Pathologies associated with a homozygous loss of Cav1.3 function are well-studied and generally result in a number of heart conditions, including [2394]:
- Autoimmune-associated congenital heart block
- Sinoatrial node dysfunction: Autoimmune-associated sinus bradycardia
- Atrioventricular node dysfunction: Autoimmune-associated atrioventricular block
- Atrioventricular node dysfunction
- Atrial fibrillation
- Heart failure
Interestingly, these seem to go hand in hand with congenital deafness In mouse models, genetic deletion of Cav1.3 also caused congenital deafness, sinus bradycardia, and various degrees of atrioventricular (AV) block consistent with region-specific expression. Furthermore, Cav1.3−/− mice display impaired Ca2+ homeostasis associated with atrial fibrillation (AF) [2394]. These pathologies are unsurprising given the expression location of Cav1.3 in both the heart and auditory sensory cells.
Adrenal disease
Mutations to CACNA1D are linked to a common subtype of aldosteronism, Idiopathic hyperaldosteronism (IHA) [2405]. The pathology manifests itself with seizures, neurological abnormalities, and intellectual disability [2406]
Aberrant Cav1.3 may also lead to the formation of Adrenal aldosterone-producing adenomas (APAs) and often result in severe hypertension due to aldosterone overproduction. Five somatic mutations in the CACNA1D gene were found, altering Gly403 or Ile770 in the channel pore's S6 segments. This lead to lower depolarized potential activation and impaired inactivation, increasing Ca(2+) influx, and stimulating aldosterone production and cell proliferation [2407].
Auxiliary subunit
Cav1.3 channels typically exist as multi-subunit complexes comprised of the main pore-forming α1 subunit, as previously described, and auxiliary subunits α2δ-2, β3 subunits [2408] [2395]
Calcium & CaM
Cav1.3 allows the passage of Ca2+ ions in and out of the cell. However, it is itself sensitive to the fluctuation concentrations of the ion and can undergo Ca2+ dependent inactivation thanks to its interaction with certain proteins, namely CAM.
- Upon Ca2+ binding CaM undergoes a conformational change that promotes inactivation: Ca2+ unbound CAM, apoCAM, binds not just to the IQ domain but also to a central midsection of the channel.
- When Ca2+ binds to the N-lobe of CaM, CaM shifts to bind a different part of the channel (NSCaTE module), causing inactivation (N-lobe CDI).
- If Ca2+ binds to the C-lobe, CaM repositions again, leading to another configuration that also results in inactivation (C-lobe CDI).
These multiple CAM C- & N-terminal binding sites are a particularity of Cav1.3, as other L-type channels generally interact only via the C-terminal by interaction with the C-terminal and, in case of Cav1.3, also N-terminal. CDI is an important autoinhibitory mechanism preventing excessive Ca2+ influx. The strength of CDI itself can be adjusted by regulating the strength of CaM binding. [2409] [2395]
Interestingly, Cav1.3 CDI is location dependent. Cav1.3 channels auditory inner hair cells (IHCs) exhibit very little CDI compared to heterologously expressed Ca(V)1.3 channels, that exhibit intense CDI. This was shown to be caused by CaM-like calcium-binding protein (CaBP) molecules, present within the organ de Corti, which eliminated the baseline CDI of the proteins. These results further highlight the importance of Ca2+ control in Cav1.3 function [2410]
Dihydropyridine
3 large classes of drugs are known to bind to Cav1.2: phenylalkylamines (PAAs), verapamil, benzothiazepines (BTZ), diltiazem, and dihydropyridines (DHP), isradipine and nifedipine. [2395]
Other proteins
A host of other proteins are known to interact with Cav1.3 and aid in the proper function of the channel. These include [2395]:
AKAP-MAP2B: Targets PKA, which is required for efficient phosphorylation and physiological regulation
AKAP-15: Enhances channel activity by recruiting PKA
Shank: Mediates synaptic clustering of Cav1.3, and interaction plays an important role in pCREB signaling
Densin: Recruits CaMKII, which enhances activity by inducing CDF
Erbin: Increases activity by enhancing VDF
Actinin2: Crosslinks SK2 K+-channels to both LTCCs
References
Helton TD
et al.
Neuronal L-type calcium channels open quickly and are inhibited slowly.
J. Neurosci.,
2005
Nov
2
, 25 (10247-51).
Schnee ME
et al.
Biophysical and pharmacological characterization of voltage-gated calcium currents in turtle auditory hair cells.
J. Physiol. (Lond.),
2003
Jun
15
, 549 (697-717).
Biophysical properties of CaV1.3 calcium channels in gerbil inner hair cells.
J. Physiol. (Lond.), 2008 Feb 15 , 586 (1029-42).
Michna M
et al.
Cav1.3 (alpha1D) Ca2+ currents in neonatal outer hair cells of mice.
J. Physiol. (Lond.),
2003
Dec
15
, 553 (747-58).
Catterall WA
et al.
International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels.
Pharmacol. Rev.,
2003
Dec
, 55 (579-81).
Roberts WM
et al.
Colocalization of ion channels involved in frequency selectivity and synaptic transmission at presynaptic active zones of hair cells.
J. Neurosci.,
1990
Nov
, 10 (3664-84).
Koschak A
et al.
alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages.
J. Biol. Chem.,
2001
Jun
22
, 276 (22100-6).
Kollmar R
et al.
Predominance of the alpha1D subunit in L-type voltage-gated Ca2+ channels of hair cells in the chicken's cochlea.
Proc. Natl. Acad. Sci. U.S.A.,
1997
Dec
23
, 94 (14883-8).
Rodriguez-Contreras A
et al.
Direct measurement of single-channel Ca(2+) currents in bullfrog hair cells reveals two distinct channel subtypes.
J. Physiol. (Lond.),
2001
Aug
1
, 534 (669-89).
Zhang SY
et al.
Role of L-type Ca(2+) channels in transmitter release from mammalian inner hair cells I. Gross sound-evoked potentials.
J. Neurophysiol.,
1999
Dec
, 82 (3307-15).
Platzer J
et al.
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels.
Cell,
2000
Jul
7
, 102 (89-97).
Striessnig J
et al.
L-type Ca2+ channels in Ca2+ channelopathies.
Biochem. Biophys. Res. Commun.,
2004
Oct
1
, 322 (1341-6).
Bibollet H
et al.
Advances in CaV1.1 gating: New insights into permeation and voltage-sensing mechanisms.
Channels (Austin), 2023Dec, 17 (2167569).
Bannister RA
et al.
Ca(V)1.1: The atypical prototypical voltage-gated Ca²⁺ channel.
Biochim. Biophys. Acta,
2013
Jul
, 1828 (1587-97).
Savalli N
et al.
The distinct role of the four voltage sensors of the skeletal CaV1.1 channel in voltage-dependent activation.
J Gen Physiol, 2021Nov01, 153 ().
Ortner NJ
CACNA1D-Related Channelopathies: From Hypertension to Autism.
Handb Exp Pharmacol, 2023, 279 (183-225).
Zaveri S
et al.
Pathophysiology of Cav1.3 L-type calcium channels in the heart.
Front Physiol, 2023, 14 (1144069).
Striessnig J
et al.
L-type Ca2+ channels in heart and brain.
Wiley Interdiscip Rev Membr Transp Signal, 2014Mar01, 3 (15-38).
Huang H
et al.
Tissue-selective restriction of RNA editing of CaV1.3 by splicing factor SRSF9.
Nucleic Acids Res, 2018Aug21, 46 (7323-7338).
Yao X
et al.
Structural basis for pore blockade of human voltage-gated calcium channel Cav1.3 by motion sickness drug cinnarizine.
Cell Res, 2022Oct, 32 (946-948).
Zampini V
et al.
Elementary properties of CaV1.3 Ca(2+) channels expressed in mouse cochlear inner hair cells.
J. Physiol. (Lond.),
2010
Jan
1
, 588 (187-99).
Marionneau C
et al.
Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart.
J. Physiol. (Lond.),
2005
Jan
1
, 562 (223-34).
Kabir ZD
et al.
L-type Ca2+ channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes.
J Physiol, 2016Oct15, 594 (5823-5837).
Mangoni ME
et al.
Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity.
Proc. Natl. Acad. Sci. U.S.A.,
2003
Apr
29
, 100 (5543-8).
Brandt A
et al.
Few CaV1.3 channels regulate the exocytosis of a synaptic vesicle at the hair cell ribbon synapse.
J. Neurosci.,
2005
Dec
14
, 25 (11577-85).
Wang Z
et al.
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.
Neuron,
2006
May
4
, 50 (443-52).
Chan CS
et al.
'Rejuvenation' protects neurons in mouse models of Parkinson's disease.
Nature,
2007
Jun
28
, 447 (1081-6).
Azizan EA
et al.
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.
Nat. Genet.,
2013
Sep
, 45 (1055-60).
Pinggera A
et al.
CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels.
Biol. Psychiatry,
2015
May
1
, 77 (816-22).
Scholl UI
et al.
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Nat. Genet.,
2013
Sep
, 45 (1050-4).
Fell B
et al.
α2δ2 Controls the Function and Trans-Synaptic Coupling of Cav1.3 Channels in Mouse Inner Hair Cells and Is Essential for Normal Hearing.
J Neurosci, 2016Oct26, 36 (11024-11036).
Ben Johny M
et al.
Dynamic switching of calmodulin interactions underlies Ca2+ regulation of CaV1.3 channels.
Nat Commun,
2013
, 4 (1717).
Yang PS
et al.
Switching of Ca2+-dependent inactivation of Ca(v)1.3 channels by calcium binding proteins of auditory hair cells.
J. Neurosci.,
2006
Oct
18
, 26 (10677-89).
Contributors: Rajnish Ranjan, Michael Schartner
To cite this page: [Contributors] Channelpedia https://channelpedia.epfl.ch/wikipages/81/ , accessed on 2024 Dec 12